Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 220-971-6 | CAS number: 2950-43-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
Link to relevant study records
- Endpoint:
- in vitro gene mutation study in bacteria
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- bacterial reverse mutation assay
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and E. coli WP2
- Details on mammalian cell type (if applicable):
- - Periodically "cleansed" against high spontaneous background: yes
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9-mix prepared from Wistar rat livers
- Test concentrations with justification for top dose:
- Exp 1: 0; 33; 100; 333; 1000; 2500; 5000 µg/plate (all strains/standard plate test)
Exp 2: 0; 10; 33; 100; 333; 1000; 2500 µg/plate (all strains/preincubation test)
Exp 3: 0; 3.3; 10; 33; 100; 333; 1000 µg/plate (TA 98/preincubation test) - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: water
- Justification for choice of solvent/vehicle: due to the good solubility of the test substance - Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- Positive controls:
- yes
- Positive control substance:
- 4-nitroquinoline-N-oxide
- 9-aminoacridine
- other: 2-aminoanthracene; N-methyl-N`-nitro-N-nitrosoguanidine; 4-nitro-o-phenylenediamine
- Details on test system and experimental conditions:
- Standard plate test
Salmonella typhimurium
Test tubes containing 2-mL portions of soft agar (overlay agar), which consists of 100 mL agar (0.8% [w/v] agar + 0.6% [w/v] NaCl) and 10 mL amino acid solution (minimal amino acid solution for the determination of mutants: 0.5 mM histidine + 0.5 mM biotin) were kept in a water bath at about 42 - 45°C, and the remaining components were added in the following order:
0.1 mL test solution or vehicle (negative control)
0.1 mL fresh bacterial culture
0.5 mL S9 mix (with metabolic activation)
or
0.5 mL phosphate buffer (without metabolic activation)
After mixing, the samples were be poured onto Minimal glucose agar plates within approx. 30 seconds. After incubation at 37°C for 48 – 72 hours in the dark, the bacterial colonies (his+ revertants) were counted. The colonies were counted using the Sorcerer Image Analysis System with the software program Ames Study Manager. Colonies were counted manually, if precipitation of the test substance hinders the counting using the Image Analysis System.
Escherichia coli
Test tubes containing 2-mL portions of soft agar (overlay agar), which consists of 100 mL agar (0.8% [w/v] agar + 0.6% [w/v] NaCl) and 10 mL amino acid solution (minimal amino acid solution for the determination of mutants: 0.5 mM tryptophan) were kept in a water bath at about 42 - 45°C, and the remaining components were added in the following order:
0.1 mL test solution or vehicle (negative control)
0.1 mL fresh bacterial culture
0.5 mL S9 mix (with metabolic activation)
or
0.5 mL phosphate buffer (without metabolic activation)
After mixing, the samples were be poured onto Minimal glucose agar plates within approx. 30 seconds. After incubation at 37°C for 48 – 72 hours in the dark, the bacterial colonies (his+ revertants) were counted. The colonies were counted using the Sorcerer Image Analysis System with the software program Ames Study Manager. Colonies were counted manually, if precipitation of the test substance hinders the counting using the Image Analysis System.
Preincubation Test
0.1 mL test solution or vehicle, 0.1 mL bacterial suspension and 0.5 mL S9 mix (with metabolic activation) or phosphate buffer (without metabolic activation) were incubated at 37°C for the duration of about 20 minutes using a shaker. Subsequently, 2 mL of soft agar was added and, after mixing, the samples were poured onto the agar plates within approx. 30 seconds.
After incubation at 37°C for 48 – 72 hours in the dark, the bacterial colonies were counted. The colonies were counted using the Sorcerer Image Analysis System with the software program Ames Study Manager (Perseptive Instruments Ltd., Haverhill, UK). Colonies were counted manually, if precipitation of the test substance hindered the counting using the Image Analysis System.
In each experiment 3 test plates per dose or per control were used.
The following positive controls were used to check the mutability of the bacteria and the activity of the S9 mix:
With S9 mix
• 2-aminoanthracene (2-AA) (TA 1535, TA 100, TA 1537, TA 98, Escherichia coli WP2 uvrA)
Without S9 mix
• N-methyl-N'-nitro-N-nitrosoguanidine (TA 1535, TA 100)
• 4-nitro-o-phenylenediamine( TA 98)
• 9-aminoacridine (AAC) (TA 1537)
• 4-nitroquinoline-N-oxide (4-NQO(E. coli WP2 uvrA) - Evaluation criteria:
- The test substance was considered positive in this assay if the following criteria were met:
• A dose-related and reproducible increase in the number of revertant colonies, i.e. at least doubling (bacteria strains with high spontaneous mutation rate, like TA 98, TA 100 and E.coli WP2 uvrA) or tripling (bacteria strains with low spontaneous mutation rate, like TA 1535 and TA 1537) of the spontaneous mutation rate in at least one tester strain either without S9 mix or after adding a metabolizing system. - Species / strain:
- S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and E. coli WP2
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- TOXICITY: A bacteriotoxic effect was observed depending on the strain and test conditions from about 100 μg/plate onward.
SOLUBILITY: No precipitation of the test substance was found with and without S9 mix.
A relevant increase in the number of his+ or trp+ revertants was not observed in the standard plate test or in the preincubation test either without S9 mix or after the addition of a metabolizing system. - Remarks on result:
- other: all strains/cell types tested
- Remarks:
- Migrated from field 'Test system'.
- Conclusions:
- Thus, under the experimental conditions of this study, the test substance Hydroxylamine-O-sulphonic acid is not mutagenic in the Salmonella typhimurium/Escherichia coli reverse mutation assay in the absence and the presence of metabolic activation.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Additional information
Bacterial in vitro assay:
Only limited data are available for the test substance to evaluate the mutagenic potential.
An Ames test was performed with Hydroxylamine-O-sulphonic acid for its mutagenic potential based on the ability to induce point mutations in selected loci of several bacterial strains, as Salmonella typhimurium and Escherichia coli, in a reverse mutation assay (BASF, 2015).
The test substance was exposed at concentrations of 33 µg - 5000 µg/plate (Standard plate test) and 3.3 µg - 2500 µg/plate (preincubation test) to the test strains TA 1535, TA 100, TA 1537, TA 98 and E. coli WP2 uvrA with and without S9 mix. A relevant increase in the number of his+ or trp+ revertants was not observed in the standard plate test or in the preincubation test either without S9 mix or after the addition of a metabolizing system A bacteriotoxic effect was observed depending on the strain and test conditions from about 100 μg/plate onward. Thus, under the experimental conditions of this study, the test substance Hydroxylamine-O-sulphonic acid is not mutagenic in the Salmonella typhimurium/ Escherichia coli reverse mutation assay in the absence and the presence of metabolic activation.
In an older Ames test performed with hydroxylamine-O-sulphonic acid (BASF, 2003), several Salmonella typhimurium strains were exposed to the test substance as follows: 20, 100, 500, 2500 and 5000 µg/plate (TA 98, TA 100 first experiment), 125, 250, 500, 750 and 1000 µg/plate (TA 98, TA 100 second experiment) and 125, 250, 500, 1000 and 2000 µg/plate (TA 102). No increase in the number of his+ revertants was observed in the standard plate test, with or without the addition of S9 mix in all S. typhimurium strains tested (TA98, TA100, TA102). A bacteriotoxic effect (reduced his- background growth) was observed in the standard plate test with and without S9-mix at concentrations > 500-750 µg per plate. The results of the negative and positive controls were as expected and confirmed the validity and sensitivity of the test system used.
In another bacterial reverse mutation test, Hydroxylamine-O-sulfonic acid was only mutagenic in the excision-repair proficient strain his G 46, but failed to induce mutations in the excision repair deficient strain TA 100. At a concentration of 5 mg/plate hydroxylamine-O-sulfonic acid inhibited growth of his G 46 and TA 100 (Kalus, 1987).
Furthermore, in another bacterial in vitro test / in situ investigation on DNA it was demonstrated that hydroxylamine-O-sulphonic acid evoked changes in DNA molecules, documented by spectroscopic measurements, and inhibited the pol A-strain preferentially in the (pol A+/pol A- assay) (Rosenkranz, 1973). The positive result in the non-standard bacterial Rec-assay was also observed in further experiments published by the same author. The test substance hydroxylamine-O-sulfonic acid displayed a positive result in the non-relevant E.coli-based Pol A+/Pol A- assay. Nevertheless, negative results were obtained in the Ames test with Salmonella typhimurium TA1535 and TA1538 (Rosenkranz, 1976).
Other findings:
A publication of Kawazoe (1972) investigated the reaction of guanosine, a target moiety of DNA presumably involved in certain chemical carcinogenesis, with hydroxylamine-O-sulfonic acid. Results may suggest a possibility that amination with hydroxylamine-0-sulfonic acid might be a model for the DNA damage involved in carcinogenesis by N-arylhydroxylamines.
However, no further data are available to DNA-binding of the test substance in mammalian cells and no data on in vitro tests of mammalian cells.
Conclusion:
Based on the limited data set with equivocal results from different tests in bacterial systems, no conclusion on classification and labeling can be drawn. Data of mutagenicity testing in mammalian cells is lacking.
Justification for selection of genetic toxicity endpoint
Estimated Klimisch rating: 1
Justification for classification or non-classification
Equivocal effects were observed in in vitro mutagenicity testings with hydroxylamine-O-sulphonic acid (CAS 2950-43-8). Due to contradictory results and lack of data no conclusion on classification is possible according to Classification, Labelling, and Packaging Regulation (EC) No 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.